RichardHWeislerMD

PubMed

• 3 citations
  Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression.
  C Brendan Montano, W Clay Jackson, Denise Vanacore, Richard Weisler
  Postgraduate Medicine. 2023-06-01
• 4 citations
  Practical Advice for Primary Care Clinicians on the Safe and Effective Use of Vortioxetine for Patients with Major Depressive Disorder (MDD).
  C Brendan Montano, W Clay Jackson, Denise Vanacore, Richard H Weisler
  Neuropsychiatric Disease and Treatment. 2022-01-01
• A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults.
  Cynthia Richards, Dan V. Iosifescu, Rajnish Mago, Elias Sarkis, Brooke Geibel
  Journal of Clinical Psychopharmacology. 2018-08-01

Journal Articles

• A Call to Action in the Wake of the Newtown Massacre  
  Brett Stetka, MD, Richard H. Weisler, MD, Joseph J. Parks, MD, Henry A. Nasrallah, MD, Medscape Psychiatry, 1/22/2013
• The Association of the Effect of Lithium in the Maintenance Treatment of Bipolar Disorder with Lithium Plasma Levels: A Post-hoc Analysis of a Double-blind Study Compa...  
  W.A. Nolen, R. H. Weisler, Bipolar Disorders – An International Journal of Psychiatry and Neurosciences, 12/10/2012
• Lamotrigine vs. Lamotrigine Plus Divalproex in Randomized, Placebo-Controlled Maintenance Treatment for Bipolar Depression  
  Bowden CL, Singh V, Weisler R, Thompson P, Chang X, Quinones M, Mintz J, Acta Psychiatrica Scandinavica, 6/1/2012
• Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Withdrawal Design  
  Matthew Brams, MD; Richard Weisler, MD; Robert L. Findling, MD, MBA; Maria Gasior, MD, PhD; Mohamed Hamdani, MS; M. Celeste Ferreira-Cornwell, Ph.D; and Liza Squires, MD, Journal of Clinical Psychiatry, 5/17/2012
• Attention Deficit Hyperactivity Disorder Subtypes and Symptom Response in Adults Treated with Lisdexamfetamine Dimesylate  
  Greg Mattingly, MD; Richard Weisler, MD; Bryan Dirks, MD; Thomas Babcock, DO; Ben Adeyi, MS; Brian Scheckner, PharmD; and Robert Lasser, MD, Innovations in Neuroscience, 5/1/2012
• Randomized Clinical Study of a Histamine H3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder  
  Richard H. Weisler, Gahan J. Pandina, Ella J. Daly, Kimberly Cooper, and Cristiana Gassmann-Mayer, for the 31001074-ATT2001 Study Investigators, CNS Drugs, 1/1/2012
• Analysis of Suicidality in Pooled Data From 2 Double-Blind, Placebo-Controlled Aripiprazole Adjunctive Therapy Trials in Major Depressive Disorder  
  R.H. Weisler, A Khan, M.H. Trivedi, H. Yang, J.M. Eudicone, A. Pikalov, Q.V. Tran, R.M. Berman, and B.X. Carlson, Journal of Clinical Psychiatry, 4/1/2011
• A National Epidemic of Unintentional Prescription Opioid Overdose Deaths: How Physicians Can Help Control It  
  Leonard J. Paulozzi, MD, MPH; Richard H. Weisler, MD; and Ashwin A Patkar, MD, MRCPsych, Journal of Clinical Psychiatry, 3/22/2011
• At War with Mental Illness: Caring for Troops and Veterans  
  Bret Stetka, MD; Richard H. Weisler, MD; Henry Nasrallah, MD; Harold Kudler, MD, Medscape Psychiatry & Mental Health, 2/10/2011
• Treating Attention-Deficit/Hyperactivity Disorder in Adults: Focus on Once-Daily Medications  
  Richard H. Weisler, MD, Ann C. Childress, MD, Primary Care Companion CNS Disorders, 1/1/2011
• Posttraumatic Stress Disorder Screening Practices: A 2010 Internet Asssessment of Customary Care  
  Brown, J, Weisler, RH, 1/1/2011
• Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder  
  Richard H. Weisler, 1/1/2011
• A Randomized, Placebo-Controlled, Multicenter Study of Divalproex Sodium Extended-Release in the Acute Treatment of Mania  
  Robert M.A. Hirschfeld, MD; Charles L. Bowden, MD; Namita V. Vigna, PhD; Patricia Wozniak, PhD; and Michelle Collins, PhD, Physicians Postgraduate Press, Inc, publishers of The Journal of Clinical Psychiatry, 3/9/2010
• Interpreting ADHD Rating Scale Scores: Linking ADHD Rating Scale Scores and CGI Levels in Two Randomized Controlled Trials of Lisdexamfetamine Dimesylate in ADHD  
  David Goodman, MD, Stephen V. Faraone, PhD, Lenard A. Adler, MD Bryan Dirks, MD, Mohamed Hamdani, MS, Richard Weisler, MD, Primary Psychiatry, 3/1/2010
• Analysis of Classes Used in the Treatment of Depression by Physician-reported Severity  
  Susan Lenderts, BA; Amir H. Kalali, MD; Richard H. Weisler, MD, Trend Watch, 2/1/2010
• How do you choose a second-line treatment option for depression?  
  Weisler, RH, Journal of Clinical Psychiatry, 1/1/2010
• Levetiractem in General Social Anxiety Disorder: A Double-Blind, Randomized Controlled Trial  
  Stein MB, Ravindran LN, Simon NM, Liebowitz MR, Khan A, Brawman-Mintzer O, Lydiard RB, Pollack MH and study group, Journal of Clinical Psychiatry, 12/1/2009
• Effect of Lisdexamfetamine Dimesylate on Sleep in Adults with Attention Deficit/Hyperactivity Disorder  
  Adler LA, Goodman D, Weisler R, Hamdani M, Roth T, Behavioral & Brain Functions, 8/1/2009
• Extended-Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Study  
  Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H; Moonstone Study Group, CNS Spectrum, 6/1/2009
• Maintenance Treatment for Patients with Bipolar I Disorder: Results from a North American Study of Quetiapine in Combination with Lithium or Divalproex (Trial 127)  
  Suppes T, Vieta E, Liu S, Brecher M, Paulsson B; Trial 127 Investigators, American Journal of Psychiatry, 4/1/2009
• Short-Term Effects of Lisdexamfetamine Dimesylate on Cardiovascular Parameters in a 4-Week Clinical Trial in Adults With Attention-Deficit/Hyperactivity Disorder  
  Leonard A. Adler, MD; Richard H. Weisler, MD; David W. Goodman, MD; Mohamed Hamdani, MS and Gwendolyn E. Niebler, DO, Journal of Clinical Psychiatry, 1/1/2009
• Attention-Deficit/Hyperactivity Disorder-Specific Quality of Life with Triple-Bead Mixed Amphetamine Salts (SPD465) in Adults: Results of a Randomized, Double-Blind, P...  
  Spencer TJ, Landraf JM, Adler LA, Weisler RH, Anderson CS, Youcha SH, Journal of Clinical Psychiatry, 11/1/2008
• Triple-Bead, Mixed Amphetamine Salts (SPD465), A Novel, Enhanced Extended-Release Amphetamine Formulation for the Treatment of Adults with ADHD: A Randomized, Double-B...  
  Spencer TJ, Adler LA, Weisler RH, Youcha SH, Journal of Clinical Psychiatry, 9/1/2008
• Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults with Attention-deficit/Hyperactivity Disorder  
  Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J; 303 Study Group, Journal of Clinical Psychiatry, 9/1/2008
• Varying Uses of Anticonvulsant Medications  
  Casade E, Kalali AH, Weisler RH, Trend Watch, 6/1/2008
• Join now to see all

Books/Book Chapters

• Psychopharmacology: The Fourth Generation of Progress 
  Chapter: Economic Evaluation of Drug Treatment for Psychiatric Disorders: The New Clinical Trial Protocol 
  Zarkin GA, Grabowski H, Mauskopf JA, Luckey H, Bannerman MPA1995

Abstracts/Posters

• Extended Release Quetiapine Fumarate (Quetiapine XR) in Acute and Maintenance Studies in Major Depressive Disorder (MDD): Suicidality Data
  Weisler RH, 9th International Forum on Mood and Anxiety Disorders (FMAD) in Monaco Monte-Carlo, 11/11/2009
• Cardiovascular Outcomes in Children and Adults Treated With Lisdexamfetamine Dimesylate for Attention-Deficit/Hyperactivity Disorder
  Weisler RH, (AACAP) American Academy of Child Psychiatry in Honolulu, HI, 10/27/2009
• Efficacy & Tolerability of One-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Major Depressive Disorder (MDD): Pooled Analysis...
  Weisler RH, (ACNP) American College of Neuropsychopharmacology in Scottsdale, AZ, 12/7/2008
• Effect of Lisdexamfetamine Dimesylate on Sleep Quality in Adults with Attention-Deficit/Hyperactivity Disorder
  G Mattingly, MD; D Goodman, MD; L Adler, MD; R Weisler, MD; M Hamdani, MS; T Roth, PhD, (IPS) 60th Institute on Psychiatric Services in Chicago, IL, 10/2/2008
• Evaluation of Cardiovascular Effects of Lisdexamfetamine Dimesylate Treatment in Adults with Attention Deficit/Hyperactivity Disorder
  RH Weisler, MD; TE Wilens, MD; D Goodman, MD; L Adler, MD; G Neibler, DO; J Biederman, MD, (IPS) 60th Institute on Psychiatric Services in Chicago, IL, 10/2/2008
• Analysis of Suicidality in Pooled Data from Two Double-Blind, Placebo-Controlled Aripiprazole Adjunctive Therapy Trials in Major Depressive Disorder
  RH Weisler, MD; Huyan Yang, Ph.D; RD McQuade, MD; BX Carlson, Ph.D; RN Marcus MD, RM Berman, MD, (IPS) 60th Institute on Psychiatric Services in Chicago, IL, 10/2/2008
• Extended Release Quetiapine Fumarate (quetiapine XR) Monotherapy for Major Depressive Disorder (MDD): A Double-Blind, Placebo-Controlled Study
  R Weisler, M Joyce, L McGill, A Lazarus, H Eriksson, (IPS) 60th Institute on Psychiatric Services in Chicago, IL, 10/2/2008
• Effect on Functioning, Cognition, and Productivity of Quetiapine or Lithium Monotherapy versus Placebo for Maintenance Treatment of Bipolar I Disorder
  Weisler RH, (IPS) 60th Institute on Psychiatric Services in Chicago, IL, 10/2/2008
• Quetiapine or Lithium versus Placebo for Maintenance Treatment of Bipolar I Disorder After Stabilization on Quetiapine
  RH Weisler, WA Nolen, A Neijber, A Hellqvist, B Paulsson, (IPS) 60th Institute on Psychiatric Services in Chicago, IL, 10/2/2008
• Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy for Major Depressive Disorder (MDD): A Double-Blind, Placebo-Controlled Study
  Weisler RH, APA Annual Meeting in Washington, DC, Washington Convention Center, 5/3/2008
• Quetiapine Monotherapy is Efficacious for Depressive Episodes of Bipolar I Disorder: Combined Results from Two Double Blind Placebo-Controlled Studies
  Richard H. Weisler, Robert Arvekvist, Goran Stening, Fifth European Conference on Bipolar Disorder, Auditori Sant Joan de Deu Esplugues, Barcelonia, Cata, 1/1/2006
• Efficacy of Extended-Release Carbamazepine in Bipolar Disorder: Short and Long Term Results
  Richard H. Weisler, MD, Robert Hirschfeld, MD, Andrew J. Cutler, MD, Thomas Gazda, MD, Terence Ketter, MD, Paul Keck MD, Alan Swann MD, and Amir Kalali, MD, USMH ( US Psychiatric & Mental Health Congress, 11/1/2005
• Extended-Release Carbamazepine for Manic Episodes in Bipolar I Disorder
  Weisler RH, 57th IPS (Institute on Psychiatric Services), San Diego, CA, 10/5/2005
• Efficacy of Carbamazepine Capsules in Bipolar Disorder
  Weisler RH, Sixth International Conference on Bipolar Disorder, 1/1/2005
• Efficacy of Carbamazepine Capsules in Bipolar Disorder
  Weisler RH, Bipolar Disorders, 1/1/2005
• Elevated Resident Suicide Rates and Toxin Release From Nearby Plants: A Potential Link
  Weisler, RH, Davidson, JRT, Zeller, L, Taylor-Guevera, H, Singlton, SS, LM, Fiffer, MR, Tsougas, U.S. Psychiatric & Mental Health Congress. San Diego, CA, 11/19/2004
• Cardiovascular Effects of Adderall XR in Adult ADHD
  Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter T, Keck P, Kalali., U.S. Psychiatric & Mental Health Congress. San Diego, CA, 11/19/2004
• Efficacy of Extended-Release Carbamazepine in Bipolar Disorder: Results of Two Pooled Clinical Trials
  Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter T, Keck P, Kalali, U.S. Psychiatric & Mental Health Congress. San Diego, CA, 11/18/2004
• Safety and Tolerability of Extended-Release Carbamazepine in Bipolar Disorder: Results of Two Pooled Clinical Trials
  Weisler RH, Hirschfeld R, Cutler AJ, Gazda T, Ketter T, Keck P, Kalali., U.S. Psychiatric & Mental Health Congress. San Diego, CA, 11/18/2004
• Carbamazepine Extended Release Treatment of Manic and Mixed Symptoms
  Weisler, Richard H., M.D, Ketter, Terence A., M.D. and Kalali, Amir H., M.D, 157 Annual American Psychiatric Association Meeting, New York, NY, 5/1/2004
• Treatment of Manic and Mixed Patients with Carbamazepine Extended
  Weisler, Richard H., M.D. Co-authors Keck, Jr., Paul E., M.D.and Swann, Alan C., M.D., 157 Annual American Psychiatric Association Meeting, New York, NY, 5/1/2004
• Long-Term Safety and Efficacy of Mixed Amphetamine Salts Extended for Adult ADHD
  Biederman, Joseph, M.D., Weisler, Richard, M.D., Tulloch, Simon J., M.D., Wilens, Timothy E., M.D., Chrisman, Allan K., M.D., 157 Annual American Psychiatric Association Meeting, New York, NY, 5/1/2004
• Adjunctive Ziprasidone in Bipolar Mania: Short-Term and Long-Term Data
  Patricia English, Ph.D, Lewis Warrington, and Judith Ann, Ph.D., 157 Annual American Psychiatric Association Meeting, New York, NY, 5/1/2004
• Dose-Response Efficacy of Mixed Amphetamine Salts Extended for Adult ADHD
  Faraone, Stephen V., M.D., Biederman, Joseph, M.D., Spencer, Thomas J., M.D., Wilens, Timothy E., M.D., Read, Stephanie C., M.S., Zhang, Yuxin, Ph.D., Tulloch, Simon J..., 157 Annual American Psychiatric Association Meeting, New York, NY, 5/1/2004
• Three-Bead Extended-Release Carbamazepine Capsule (SPD417) Continue Maintenance Therapy in Bipolar Disorder
  Ketter, Terence A., M.D. Weisler, Richard H., M.D., Kalali, Amir H., M.D., 157 Annual American Psychiatric Association Meeting, New York, NY, 5/1/2004
• Join now to see all

Lectures

• Psychopharmacology Update 
  Quadrant HealthCom, Inc., Cincinnati, Ohio - 10/20/2012
• Lisdexamfetamine Dimesylate Effects on Self-Reported Executive Function and Quality of Life in Adults With Attention-Deficit/Hyperactivity Disorder: Focus on Emotional... 
  NCDEU 52nd Annual Meeting at the Arizona Biltmore Resort, Phoenix, AZ - 5/31/2012
• Relationship of ADHD Symptom and Global Severity Assessments in Adults With ADHD and Executive Function Deficits Treated With Lisdexamfetamine Dimesylate 
  NCDEU 52nd Annual Meeting at the Arizona Biltmore Resort, Phoenix, AZ - 5/31/2012
• Lisdexamfetamine Dimesylate Impact on 2 Subjective Quality-of-Life Scales in Adult Attention-Deficit/Hyperactivity Disorder and Executive Dysfunction 
  APA’s 165th Annual Meeting at the Pennsylvania Convention Center, Philadelphia PA - 5/5/2012
• Efficacy of Lisdexamfetamine Dimesylate on Self- and Informant-Reported Executive Dysfunction in Adults With Attention-Deficit/Hyperactivity Disorder 
  APA’s 165th Annual Meeting at the Pennsylvania Convention Center, Philadelphia PA - 5/5/2012
• Maintenances and Efficacy of Lisdexamfetamine Dimesylate in Adults with Attention Deficit/Hyperactivity Disorder: Double-Blind, Randomized Withdrawal Design 
  24th Annual US Psychiatric and Mental Health Congress in Las Vegas, NV - 11/6/2011
• Balancing Treatment Decisions Beyond First-Line Therapy For Major Depressive Disorder: Pharmacotherapeutic And Psychotherapeutic Options 
  Canadian Psychiatric Association. Vancouver, Canada - 10/14/2011
• Treating the Symptomatic Burden of Bipolar Depression & Major Depressive Disorder 
  Astrazeneca Satellite Symposium 19th EPA Congress, Austria, Vienna - 3/1/2011
• Examination of Effects of Lisdexamfetamine Dimesylate on Sleep Quality in studies of Adults with Attention-Deficit/Hyperactivity Disorder 
  (APA) American Psychiatric Association Annual Meeting in New Orleans, LA - 5/22/2010
• Quetiapine or Lithuim Versus Placebo for Maintenance Treatment of Bipolar I Disorder After Stabilization on Quetiapine 
  Pittsburg, PA - 6/25/2009
• Linking Attention-Deficit/Hyperactivity Disorder Ratings and Clinical Global Impressions Scores in Studies of Lisdexamfetamine Dimesylate in Attention-Deficit/Hyperact... 
  APA (American Psychiatric Association) in San Francisco, CA - 5/18/2009
• Extended-Release Quetiapine Fumarate (Quetiapine XR) in Major Depressive Disorder (MDD): Suicidality Data from Acute and Maintenance Studies 
  APA in San Francisco, CA - 5/16/2009
• Response and Symptomatic Remission in a Long-Term Trial of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder 
  APA 162nd Annual Meeting of the American Psychiatric Association in San Francisco, CA - 5/16/2009
• Internal Consistency and Validity of the ADHD Rating Scale IV with Adult ADHD Prompts 
  APA in San Francisco, CA - 5/16/2009
• Long-Term Safety & Efficacy of Lisdexamfetamine Dimesylate in Adults with Attention Deficit/Hyperactivity Disorder 
  (WPA) World Psychiatric Association in Florence, Italy - 4/4/2009
• Posttraumatic Stress Disorder in Combat Veterans: Identifying and Treating the Increasing Prevalence of Anxiety in Today’s Soldiers 
  (NEI) Neuroscience Education Institute Conference in Carlsbad, CA - 11/11/2008
• Efficacy And Safety Of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) As Monotherapy For Major Depressive Disorder: A Randomized, Placebo-Controlled S... 
  NCDEU - 1/1/2008
• Analysis of Suicidality in Pooled Data from Two Double-Blind, Placebo-Controlled Aripiprazole Adjunctive Therapy Trials in Major Depressive Disorder 
  (ACNP) 46th American College of Neuropsychopharmacology Annual Meeting, Boca Raton Resort & Club, FL - 12/9/2007
• The Role of Quetiapine in the Management of Acute Bipolar Depression: A New Option for Both Bipolar I and Bipolar II Patients 
  (WPA) “Working Together for Mental Health.. Partnerships for Policy/ Practice 2007 World Psychiatric - 11/28/2007
• Quetiapine Monotherapy for Treating Depressive Episodes of Bipolar Disorder 
  (IPS) 59th Institute of Psychiatric Services Conference, New Orleans, LA - 10/11/2007
• 10 Years of Quetiapine in Clinical Practice 
  59th Institute of Psychiatric Services Conference, New Orleans, LA - 10/11/2007
• Bipolar Depression: Diagnosis, Recognition, and Treatment Experience With Quetiapine 
  American Osteopathic Association 112th Annual Convention and Scientific Seminar, San Diego, CA - 9/30/2007
• Efficacy of Quetiapine Monotherapy in Bipolar I Depression: Combined Results From Two Double-Blind, Placebo-Controlled Studies 
  CINP (Congress of the Collegium Internationale of Neuropsychopharmacologicum). Lakeside Center, McCo - 7/9/2006
• Comparative Efficacy of Twice-Daily and Once-Daily Extended-Release Carbamazepine in Bipolar Disorder: Results from a Double-Blind, Parallel-Group Trial 
  NCDEU Mtg , Boca Raton Resort & Club, Boca Raton, FL - 6/13/2006
• The Safety of Combination Therapy with Carbamazepine Extended-Release Capsules for Bipolar I Disorder 
  APA Annual Meeting - 5/1/2006
• Join now to see all

Other

• “Psyche Resources in the Military” (WebMD expert interview) 
  Richard H. Weisler
  http://www.medscape.com
  1/1/2011
• “Addressing Accidental Overdose” (WebMD video commentary) 
  Richard H. Weisler
  http://www.medscape.com
  APA Conference in New Orleans, LA - 5/22/2010
• “Adult ADHD Findings” (WebMD Video commentary & expert interview) 
  Richard H. Weisler, Medscape Psychiatry & Mental Health
  APA Conference in New Orleans, LA - 5/22/2010
• “Wounded Warriors” General Grange & Robin Kelleher 
  Richard H. Weisler, John Boy & Billy Bob Show
  10/15/2009
• Adult ADHD and the DSM V ( Live videotape panelist spotlight) 
  Richard H. Weisler, MD, David Goodman & two other experts, Medscape Psychiatry & Mental Health
  APA Meeting in San Francisco, CA - 5/19/2009
• “ADHD Treatment”, Health View Program” Dr. Angela Ruff 
  Richard H. Weisler
  2/16/2008
• “Surviving the Highs and Lows Associated with Bipolar Disorder”. An eight program radio tour 
  Richard H. Weisler, OTSP (On The Scene Productions) (Richmond News, National News, Odessa “Morning Magazine” Program, Ot
  1/1/2006
• Post-Disaster Psychiatry: Lessons From Katrina (Live Interview) 
  Richard H. Weisler, MD; Allan Chrisman, M.D.; Mark Townsend, M.D., Medscape.com
  http://www.medscape.com/psychiatry
  1/1/2006
• Special Report – CME Certified: Do No Harm: Safe Use Of New Pharmacologic Agents For Bipolar Disorder (Medical Periodical jointly sponsored by Shire & SUNY Upstate Med... 
  Richard H. Weisler, MD, Alan C. Swann, M.D., Andrew J. Cutler, M.D., Lawrence D. Ginsberg, M.D., Terence A. Ketter, M.D.
  10/1/2005
• Do No Harm: Safe Use of New Pharmacologic Agents for Bipolar Disorder (ICBD CME Straight Talk, discussant) 
  Richard H. Weisler
  ICBD Conference - 6/17/2005
• Bipolar Disorder: What’s New in Mood Stabilization for Mania & Mixed States? 
  Terrence A. Ketter, M.D. & Richard H. Weisler, MD
  5/24/2005
• Suicide,Cancer, and the Environment 
  Richard H. Weisler, UNC TV: NC Now
  1/1/2005
• Post-traumatic Stress after 9-11 
  Richard H. Weisler, UNC TV
  1/1/2001
• “Surviving Depression”, program for the North Carolina Depressive & Manic Depressive Association. 
  Richard H. Weisler, Community TV
  1/1/1996
• Honors Thesis – Tulane University, “Role Relevant Skills Variable as a Predictor of Hypnotic Susceptibility” 
  Weisler RH
  1/1/1972
• Join now to see all